NCT00271401View on ClinicalTrials.gov

A Study Comparing the Efficacy and Safety of Intracoronary Stenting With or Without Abciximab, an Anti-Platelet Therapy, and Conventional Coronary Angioplasty With Abciximab

PHASE3CompletedINTERVENTIONAL
Enrollment

2,399

Participants

Timeline

Start Date

July 31, 1996

Primary Completion Date

September 30, 1997

Study Completion Date

September 30, 1997

Conditions
Angioplasty, Transluminal, Percutaneous Coronary
Interventions
OTHER

Angioplasty

OTHER

Intracoronary Stent

DRUG

Abxicimab

DRUG

Heparin

DRUG

Placebo

Sponsors

Lead Sponsor

Centocor, Inc.
All Listed Sponsors
lead

Centocor, Inc.

INDUSTRY